Aspire Health Science

Aspire Health Science is a private, US-based CDMO founded in 2017, providing comprehensive services for cellular therapy developers. Its core offering includes manufacturing, process development, research, quality control, and consulting, all conducted within its ISO Class 7 cleanroom and laboratories. The company operates as a service provider, supporting client therapies from conception through commercialization, and is currently in a revenue-generating stage by serving biotech companies and researchers.

FDA-registered, cGMP-compliant manufacturing facility with ISO Class 7 cleanrooms, QC and R&D labs. Offers end-to-end CDMO services for cellular therapies, including process development, scale-up, manufacturing, and testing.

Aspire competes in the crowded cell therapy CDMO space against large global players (e.g., Lonza, Catalent) and many specialized firms. Differentiation is critical, likely through personalized service, technical expertise in specific cell types, or its affiliation with the HealthBanks network.